Abpro Holdings, Inc.
Abpro Holdings, Inc. is a publicly traded company listed on the OTC market under the ticker symbol ABPO [2]. The company is headquartered at 6 St Johns Lane, Floor 5, New York, NY, 10013 [1]. According to SEC classification, Abpro Holdings operates in the biological products industry, specifically in products excluding diagnostic substances [3]. The company was formerly registered with the SEC under the name Atlantic Coastal Acquisition Corp. II from December 2, 2021 to November 12, 2024 [4]. In its most recent annual report, Abpro Holdings reported revenue of $183,000 for the year ending December 31, 2024, and total assets of $1.1 million [5].
NYC headquarters
- SEC filings list the business address of Abpro Holdings, Inc. as 6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013.[1]
financials
- Reported revenue of $183,000 for the year ending 2024-12-31 and total assets of $1.1 million in its most recent annual report to the SEC.[5]
Something wrong or missing? Send a correction. Fixed within 24 hours.